If upcoming clinical trials prove it’s safe for adult sickle cell patients to ingest tranylcypromine, the anti-depressant could be an alternative to the current treatment. © JJAVA - Fotolia.com by Katti Gray, theGrio After more than three decades of studying life-threatening sickle cell disease, the most prevalent of all hereditary illnesses, University of Michigan Medical School resear...
Article courtesy of USA TODAY U.S. home prices are coming off the bottom faster than many e...
Cancer Researchers Says Doctor Shares Q&A for Cancer Patients Seeking Experimental Treatments ...
© 2011 Milwaukee Community Journal. All Rights Reserved
News by MCJ